Hemostatic Effect of Tranexamic Acid Combined With Factor VIII Concentrate in Prophylactic Setting in Severe Hemophilia A: a preclinical study.

CONCLUSION: Our results suggest a potential benefit of TXA when used in combination with FVIII in prophylactic setting.
PMID: 31782901 [PubMed - as supplied by publisher]

Source: Thrombosis and Haemostasis - November 28, 2019 Category: Hematology Authors: Janbain M, Enjolras N, Bordet JC, Bolbos R, Brevet M, Leissinger C, Dargaud Y Tags: J Thromb Haemost Source Type: research